cme

Vestibular disorders

Diagnosis, new classification and treatment

Dtsch Arztebl Int 2020; 117: 300-10. DOI: 10.3238/arztebl.2020.0300

Strupp, M; Dlugaiczyk, J; Ertl-Wagner, B B; Rujescu, D; Westhofen, M; Dieterich, M

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Neurologische Klinik Ludwig-Maximilians-Universität, München: Prof. Dr. med. Michael Strupp, Prof. Dr. med. Marianne Dieterich
Deutsches Zentrum für Schwindel und Gleichgewichtsstörungen, Ludwig-Maximilians-Universität, München: Prof. Dr. med. Michael Strupp, Prof. Dr. med. Julia Dlugaiczyk, Prof. Dr. med. Marianne Dieterich
Medical Imaging, University of Toronto, Kanada: Prof. Dr. med. Birgit Bettina Ertl-Wagner
Klinik und Poliklinik für Psychiatrie, Psychotherapie und Psychosomatik der Martin-Luther-Universität, Halle-Wittenberg: Prof. Dr. med. Dan Rujescu
Klinik für Hals-Nasen-Ohrenheilkunde und Plastische Kopf- und Halschirurgie, Uniklinik Aachen, RWTH Aachen: Prof. Dr. med. Martin Westhofen
Munich Cluster for Systems Neurology (SyNergy), München: Prof. Dr. med. Marianne Dieterich
1.Corrales CE, Bhattacharyya N: Dizziness and death: an imbalance in mortality. Laryngoscope 2016; 126: 2134–6 CrossRef MEDLINE
2.Strupp M, Fischer C, Hanss L, Bayer O: The takeaway frenzel goggles: a fresnel-based device. Neurology 2014; 83: 1241–5 CrossRef MEDLINE PubMed Central
3.Yip CW, Glaser M, Frenzel C, Bayer O, Strupp M: Comparison of the bedside head-impulse test with the video head-impulse test in a clinical practice setting: a prospective study of 500 outpatients. Front Neurol 2016; 7: 58 CrossRef MEDLINE PubMed Central
4.Strupp M, Mandala M, Lopez-Escamez JA: Peripheral vestibular disorders: an update. Curr Opin Neurol 2019; 32: 165–73 CrossRef MEDLINE
5.Strupp M, Kim JS, Murofushi T, et al.: Bilateral vestibulopathy: diagnostic criteria consensus document of the Classification Committee o f the Barany Society. J Vestib Res 2017; 27: 177–89 CrossRef MEDLINE
6.Lucieer F, Vonk P, Guinand N, Stokroos R, Kingma H, van de Berg R: Bilateral vestibular hypofunction: insights in etiologies, clinical subtypes, and diagnostics. Front Neurol 2016; 7: 26 CrossRef MEDLINE PubMed Central
7.Hall CD, Herdman SJ, Whitney SL, et al.: Vestibular rehabilitation for peripheral vestibular hypofunction: an evidence-based clinical practice guideline: from the American Physical Therapy Association Neurology Section. J Neurol Phys Ther 2016; 40: 124–55 CrossRef MEDLINE PubMed Central
8.Dunlap PM, Holmberg JM, Whitney SL: Vestibular rehabilitation: advances in peripheral and central vestibular disorders. Curr Opin Neurol 2019; 32: 137–44 CrossRef MEDLINE
9.Strupp M, Magnusson M: Acute unilateral vestibulopathy. Neurol Clin 2015; 33: 669–85 CrossRef MEDLINE
10.Rujescu D, Hartmann AM, Giegling I, et al.: Genome-wide association study in vestibular neuritis: involvement of the host factor for HSV-1 replication. Front Neurol 2018; 9: 591 CrossRef MEDLINE PubMed Central
11.Strupp M, Zingler VC, Arbusow V, et al.: Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. N Engl J Med 2004; 351: 354–61 CrossRef MEDLINE
12.Sjogren J, Magnusson M, Tjernstrom F, Karlberg M: Steroids for acute vestibular neuronitis-the earlier the treatment, the better the outcome? Otol Neurotol 2019; 40: 372–4 CrossRef MEDLINE PubMed Central
13.von Brevern M, Bertholon P, Brandt T, et al.: Benign paroxysmal positional vertigo: diagnostic criteria. J Vestib Res 2015; 25: 105–17 CrossRef MEDLINE
14.Bhattacharyya N, Gubbels SP, Schwartz SR, et al.: Clinical practice guideline: benign paroxysmal positional vertigo (Update). Otolaryngol Head Neck Surg 2017; 156 (3_suppl): S1-S47 CrossRef MEDLINE
15.Lopez-Escamez JA, Carey J, Chung WH, et al.: Diagnostic criteria for Meniere‘s disease. J Vestib Res 2015; 25: 1–7 CrossRef MEDLINE
16.Attye A, Eliezer M, Medici M, et al.: In vivo imaging of saccular hydrops in humans reflects sensorineural hearing loss rather than Meniere‘s disease symptoms. Eur Radiol 2018; 28: 2916–22 CrossRef MEDLINE
17.Adrion C, Fischer CS, Wagner J, Gurkov R, Mansmann U, Strupp M: Efficacy and safety of betahistine treatment in patients with Meniere‘s disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ 2016; 352: h6816 CrossRef MEDLINE MEDLINE
18.Hussain K, Murdin L, Schilder AG: Restriction of salt, caffeine and alcohol intake for the treatment of Meniere‘s disease or syndrome. Cochrane Database Syst Rev 2018; 12: CD012173 CrossRef MEDLINE PubMed Central
19.Thirlwall AS, Kundu S: Diuretics for Meniere‘s disease or syndrome. Cochrane Database Syst Rev 2006; 3: CD003599.
20.Pullens B, Verschuur HP, van Benthem PP: Surgery for Meniere‘s disease. Cochrane Database Syst Rev 2013; 2: CD005395 CrossRef MEDLINE
21.Tighilet B, Leonard J, Watabe I, Bernard-Demanze L, Lacour M: Betahistine treatment in a cat model of vestibular pathology: pharmacokinetic and pharmacodynamic approaches. Front Neurol 2018; 9: 43 CrossRef MEDLINE PubMed Central
22.Schoo DP, Tan GX, Ehrenburg MR, Pross SE, Ward BK, Carey JP: Intratympanic (IT) Therapies for Meniere‘s Disease: some consensus among the confusion. Curr Otorhinolaryngol Rep 2017; 5: 132–41 CrossRef MEDLINE PubMed Central
23.Brandt T, Dieterich M: Vestibular paroxysmia: vascular compression of the eighth nerve? Lancet 1994; 343: 798–9 CrossRef
24.Strupp M, Lopez-Escamez JA, Kim JS, et al.: Vestibular paroxysmia: diagnostic criteria. J Vestib Res 2016; 26: 409–15 CrossRef MEDLINE
25.Bayer O, Bremova T, Strupp M, Hufner K: A randomized double-blind, placebo-controlled, cross-over trial (Vestparoxy) of the treatment of vestibular paroxysmia with oxcarbazepine. J Neurol 2018; 265: 291–8 CrossRef MEDLINE PubMed Central
26.Strupp M, Elger C, Goldschagg N: Treatment of vestibular paroxysmia with lacosamide. Neurol Clin Pract 2019; 9: 539–41 CrossRef MEDLINE
27.Ward BK, Carey JP, Minor LB: Superior canal dehiscence syndrome: lessons from the first 20 years. Front Neurol 2017; 8: 177 CrossRef MEDLINE PubMed Central
28.Saber Tehrani AS, Kattah JC, Kerber KA, et al.: Diagnosing stroke in acute dizziness and vertigo: pitfalls and pearls. Stroke 2018; 49: 788–95 CrossRef MEDLINE PubMed Central
29.Formeister EJ, Rizk HG, Kohn MA, Sharon JD: The epidemiology of vestibular migraine: a population-based survey study. Otol Neurotol 2018; 39: 1037–44 CrossRef MEDLINE
30.Lempert T, Olesen J, Furman J, et al.: Vestibular migraine: diagnostic criteria. J Vestib Res 2012; 22: 167–72 CrossRef MEDLINE
31.Maldonado FM, Birdi JS, Irving GJ, Murdin L, Kivekas I, Strupp M: Pharmacological agents for the prevention of vestibular migraine. Cochrane Database Syst Rev 2015; 6: CD010600.
32.Feil K, Strobl R, Schindler A, et al.: What is behind cerebellar vertigo and dizziness? Cerebellum 2019; 18: 320–32 CrossRef MEDLINE
33.Strupp M, Teufel J, Zwergal A, Schniepp R, Khodakhah K, Feil K: Aminopyridines for the treatment of neurologic disorders. Neurology: Clinical Practice 2017; 7: 65–76 CrossRef MEDLINE PubMed Central
34.Kalla R, Strupp M: Aminopyridines and acetyl-DL-leucine: new therapies in cerebellar disorders. Curr Neuropharmacol 2019; 17: 7–13 CrossRef MEDLINE PubMed Central
35.Dieterich M, Staab JP: Functional dizziness: from phobic postural vertigo and chronic subjective dizziness to persistent postural-perceptual dizziness. Curr Opin Neurol 2017; 30: 107–13 CrossRef MEDLINE
36.Staab JP, Eckhardt-Henn A, Horii A, et al.: Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): consensus document of the Committee for the Classification of Vestibular Disorders of the Barany Society. J Vestib Res 2017; 27: 191–208 CrossRef MEDLINE
37.Nada EH, Ibraheem OA, Hassaan MR: Vestibular rehabilitation therapy outcomes in patients with persistent postural-perceptual dizziness. Ann Otol Rhinol Laryngol 2019; 128: 323–9 CrossRef MEDLINE
38.Yu YC, Xue H, Zhang YX, Zhou J: Cognitive behavior therapy as augmentation for sertraline in treating patients with persistent postural-perceptual dizziness. Biomed Res Int 2018; 2018: 8518631 CrossRef MEDLINE PubMed Central
39.Popkirov S, Stone J, Holle-Lee D: Treatment of persistent postural-perceptual dizziness (PPPD) and related disorders. Curr Treat Options Neurol 2018; 20: 50 CrossRef MEDLINE
e1.Neuhauser HK: The epidemiology of dizziness and vertigo. Handb Clin Neurol 2016; 137: 67–82 CrossRef MEDLINE
e2.Hulse R, Biesdorf A, Hormann K, et al.: Peripheral vestibular disorders: an epidemiologic survey in 70 million individuals. Otol Neurotol 2019; 40: 88–95 CrossRef MEDLINE
e3.Halmagyi GM, Chen L, MacDougall HG, Weber KP, McGarvie LA, Curthoys IS: The video head impulse test. Front Neurol 2017; 8: 258 CrossRef MEDLINE PubMed Central
e4.Lehnen N, Kellerer S, Knorr AG, et al.: Head-movement-emphasized rehabilitation in bilateral vestibulopathy. Front Neurol 2018; 9: 562 CrossRef MEDLINE PubMed Central
e5.Feil K, Feuerecker R, Goldschagg N, et al.: Predictive capability of an iPad-Based Medical Device (medx) for the diagnosis of vertigo and dizziness. Front Neurol 2018, 9: 29 CrossRef MEDLINE PubMed Central
e6.Shah MU, Lotterman S, Roberts D, Eisen M: Smartphone telemedical emergency department consults for screening of nonacute dizziness. Laryngoscope 2019; 129: 466–9 CrossRef MEDLINE
e7.Park MK, Lee DY, Kim YH: Risk factors for positional vertigo and the impact of vertigo on daily life: The Korean National Health and Nutrition Examination Survey. J Audiol Otol 2019; 23: 8–14 CrossRef MEDLINE PubMed Central
e8.Kim SK, Hong SM, Park IS, Choi HG: Association between migraine and benign paroxysmal positional vertigo among adults in South Korea. JAMA Otolaryngol Head Neck Surg 2019; 145: 307–12 CrossRef MEDLINE PubMed Central
e9.Sim E, Tan D, Hill K: Poor treatment outcomes following repositioning maneuvers in younger and older adults with benign paroxysmal positional vertigo: a systematic review and meta-analysis. J Am Med Dir Assoc 2019; 20: 224 CrossRef MEDLINE
e10.Tse D, Ramsay T, Lelli DA: Novel use of portable audiometry to track hearing fluctuations in Meniere‘s disease: a pilot study. Otol Neurotol 2019; 40: e130–e4 CrossRef MEDLINE
e11.Frejo L, Martin-Sanz E, Teggi R, et al.: Extended phenotype and clinical subgroups in unilateral Meniere disease: A cross-sectional study with cluster analysis. Clin Otolaryngol 2017; 42: 1172–80 CrossRef MEDLINE
e12.Gurkov R, Kantner C, Strupp M, et al.: Endolymphatic hydrops in patients with vestibular migraine and auditory symptoms. Eur Arch Otorhinolaryngol 2104; 271: 2661–7 CrossRef MEDLINE
e13.Lim MY, Zhang M, Yuen HW, Leong JL: Current evidence for endolymphatic sac surgery in the treatment of Meniere‘s disease: a systematic review. Singapore Med J 2015; 56: 593–8 CrossRef MEDLINE PubMed Central
e14.Sood AJ, Lambert PR, Nguyen SA, Meyer TA: Endolymphatic sac surgery for Meniere‘s disease: a systematic review and meta-analysis. Otol Neurotol 2014; 35: 1033–45 CrossRef MEDLINE
e15.Best C, Gawehn J, Kramer HH, et al.: MRI and neurophysiology in vestibular paroxysmia: contradiction and correlation. J Neurol Neurosurg Psychiatry 2013; 84: 1349–56 CrossRef MEDLINE
e16.Sivarasan N, Touska P, Murdin L, Connor S: MRI findings in vestibular paroxysmia—an observational study. J Vestib Res 2019; 29: 137–45 CrossRef MEDLINE
e17.Fife TD, Colebatch JG, Kerber KA, et al.: Practice guideline: cervical and ocular vestibular evoked myogenic potential testing: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology. Neurology 2017; 89: 2288–96 CrossRef MEDLINE PubMed Central
e18.Brandt T, Dieterich M: The dizzy patient: don‘t forget disorders of the central vestibular system. Nat Rev Neurol 2017; 13: 352–62 CrossRef MEDLINE
e19.Nakashima T, Pyykko I, Arroll MA, et al. Meniere‘s disease. Nat Rev Dis Primers 2016; 2:16028 CrossRef MEDLINE
e20.Strupp M, Kalla R, Claassen J, et al.: A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology 2011; 77: 269–75 CrossRef MEDLINE PubMed Central
e21.Claassen J, Spiegel R, Kalla R, et al.: A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus—effects on slowphase eye velocity, postural stability, locomotion and symptoms. J Neurol Neurosurg Psychiatry 2013; 84: 1392–9 CrossRef MEDLINE
e22.Brandt T, Dieterich M. Phobischer Attacken-Schwankschwindel, ein neues Syndrom. Münch Med Wochenschr 1986; 128: 247–50.